Acute Promyelocytic Leukemia — Trials

Acute Promyelocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01987297	Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL	unknown	Phase 4	738	Shanghai Jiao Tong University School of MedicineOTHER	1	Aug 19, 2019	clinicaltrials
NCT00196768	Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic	unknown	Phase 4	30	German AML Cooperative GroupOTHER	1	Oct 23, 2007	clinicaltrials